- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 3 Certificate of Correction to the Amended & Restated Certificate of Incorporation
- 10 Form of Performance Share Units Agreement for the 2011-2013 Performance Cycle
- 10 Form of Restricted Stock Units Agreement
- 10 Form of Restricted Stock Units Agreement
- 10 Form of 2007 Market Share Units Agreement
- 10 Senior Executive Severance Plan
- 12 Statement Re Computation of Ratios
- 21 Subsidiaries of the Registrant
- 23 Consent of Deloitte & Touche LLP
- 31 Section 302 Certification Letter
- 31 Section 302 Certification Letter
- 32 Section 906 Certification Letter
- 32 Section 906 Certification Letter
EXHIBIT 23.
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 33-33682, 33-62496, 333-114107, 333-117818 and 333-150471 on Form S-3, and Nos. 33-30856, 33-38411, 33-38587, 33-44788, 333-47403, 33-52691, 33-30756-02, 33-58187, 333-02873, 333-65424, 333-107414 and 333-144893 on Form S-8, of our reports dated February 18, 2011, relating to (1) the consolidated financial statements of Bristol-Myers Squibb Company and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph regarding the Company’s adoption of the accounting standard related to Business Combinations, effective for business combinations entered into on or after January 1, 2009) and (2) the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2010.
/s/ DELOITTE & TOUCHE LLP
Parsippany, New Jersey
February 18, 2011
E-23-1